Rare diseases
Investigational molecules
Locations
Back to Denmark1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
DenmarkStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
DenmarkStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
DenmarkStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
DenmarkStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
DenmarkStudy of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function
DenmarkStudy of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis
DenmarkStudy on Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed, Refractory, or Newly Diagnosed Multiple Myeloma
DenmarkLong-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome
DenmarkStudy of AMG 193 and IDE397 for Adults with Advanced MTAP-null Solid Tumors and Non-Small Cell Lung Cancer
DenmarkStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
DenmarkStudy on the Effects of Colchicine on Arterial Stiffness in Patients with High Blood Pressure
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.
Ongoing investigations into personalized treatment approaches for various cancer types.
Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.
Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.
Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.
Advancing treatment options for patients with moderate to severe skin conditions.
Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.
Important research advancing preventive medicine and infection control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
